Stock BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar BioLineRX Ltd. TEL AVIV STOCK EXCHANGE

Equities

IL0011015182

Chart calendar BioLineRX Ltd.

7536377ddbdcd0e093e.ssrZkihG0dgql2UTEnqCaYXGQ8HH9aDe2jtBAf3S5XA.3Jms1WYvo7JaoQt9UxPXUcOkALODhseBv1MgcoSk1ifwrZ3oTjya9UPZEg~bff0751a42068a990c33c1eea45521dd

Upcoming events on BioLineRX Ltd.

2024-05-21 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)

Past events on BioLineRX Ltd.

2024-04-16 American Society for Apheresis Meeting - Poster: Number P-28
2024-03-26 08:30 am Q4 2023 Earnings Call
2024-03-26 07:00 am Q4 2023 Earnings Release
2024-02-28 Immuno Oncology Summit
2024-02-22 07:45 pm American Society for Transplantation and Cellular Therapy and CIBMTR Meeting - Poster: Number 537
2024-02-22 07:45 pm American Society for Transplantation and Cellular Therapy and CIBMTR Meeting - Poster: Number 535
2023-12-09 American Society of Hematology Meeting
2023-11-20 10:00 am Q3 2023 Earnings Call
2023-11-20 07:00 am Q3 2023 Earnings Release
2023-09-28 02:30 pm AACR Special Conference in Cancer Research: Pancreatic Cancer
2023-09-27 05:30 pm AACR Special Conference in Cancer Research: Pancreatic Cancer
2023-09-12 08:00 am APHEXDA FDA Approval Call
2023-08-30 10:00 am Q2 2023 Earnings Call
2023-08-30 07:00 am Q2 2023 Earnings Release
2023-05-24 10:00 am Q1 2023 Earnings Call
2023-05-24 07:00 am Q1 2023 Earnings Release
2023-03-22 10:00 am Q4 2022 Earnings Call
2023-03-22 07:00 am Q4 2022 Earnings Release
2021-05-26 10:00 am Q1 2021 Earnings Call
2021-05-26 07:00 am Q1 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		4,80
0,17
2809.09%
14,4

EBITDA
Million USD		Released
Forecast
Spread 		-27,2
-25,6
-6.14%		-22,0
-21,2
-3.74%		-24,1
-25,3
4.85%		-28,5
-30,4
6.24%		-49,0
-42,4
-15.54%
-59,8

EBIT
Million USD		Released
Forecast
Spread 		-28,1
-25,5
-10.3%		-22,9
-22,1
-3.9%		-24,8
-24,4
-1.47%		-29,2
-28,5
-2.31%		-49,7
-42,1
-18.08%
-39,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-25,4
-22,2
-14.72%		-30,0
-23,3
-28.65%		-27,1
-28,9
6.43%		-25,0
-27,1
7.87%		-60,6
-58,8
-3.05%
-47,8

Net income
Million USD		Released
Forecast
Spread 		-25,4
-22,2
-14.72%		-30,0
-23,0
-30.3%		-27,1
-28,9
6.43%		-25,0
-27,1
7.87%		-60,6
-58,8
-3.05%
-47,3

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		-0,03
-0,03
0%		-0,06
-0,06
0%
-0,02

Announcement Date12/03/2023/02/2116/03/2222/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		4,80
0,17
2809.09%
0,34


0,47


0,81


4,69


6,91

EBITDA
Million USD		Released
Forecast
Spread 		-12,0
-19,0
37.02%		-11,6
-12,1
4.13%		-6,42
-7,10
9.52%		-5,91
-6,60
10.52%		-7,46
-6,80
-9.72%		-13,4
-12,9
-3.62%		-6,93
-7,70
10.06%		-8,21
-9,70
15.35%		-8,60
-8,80
2.31%		-9,72
-9,30
-4.48%		-18,3
-18,1
-1.18%		-12,1
-10,1
-20.16%		-18,5
-11,3
-64.08%
-16,8


-17,1


-33,9


-13,7


-12,2

EBIT
Million USD		Released
Forecast
Spread





-6,60
-6,23
-5.87%		-6,08
-6,80
10.55%		-7,60
-5,44
-39.87%


-7,08
-6,43
-10.1%		-8,40
-6,79
-23.69%		-8,86
-8,72
-1.61%		-9,92
-8,16
-21.58%		-18,8
-18,1
-3.71%		-12,4
-9,55
-29.36%		-18,6
-10,6
-74.44%














Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-13,4
-18,1
25.88%		-17,0
-15,6
-9.19%		-4,30
-6,15
29.96%		-4,93
-7,10
30.54%		-7,44
-5,76
-29.17%		-12,4
-11,2
-10.47%		-6,85
-6,97
1.73%		-5,73
-7,87
27.16%		-12,2
-8,74
-39.14%		-18,5
-8,62
-115.2%		-30,7
-22,5
-36.48%		-16,2
-11,0
-46.93%		-13,9
-12,1
-14.68%
-21,0


-21,3


-42,3


-17,9


-16,5

Net income
Million USD		Released
Forecast
Spread 		-13,4
-18,1
25.88%		-17,0
-15,6
-9.19%		-4,30
-6,15
29.96%		-4,93
-7,10
30.54%		-7,44
-5,76
-29.17%		-12,4
-11,2
-10.47%		-6,85
-6,97
1.73%		-5,73
-7,87
27.16%		-12,2
-8,74
-39.14%		-18,5
-8,62
-115.2%		-30,7
-22,5
-36.48%		-16,2
-11,0
-46.93%		-13,9
-12,1
-14.68%
-21,0


-21,3


-42,3


-17,9


-16,5

EPS
USD		Released
Forecast
Spread




















0,00
-0,01
-


-0,02
-0,01
-100%


-0,02
-0,01
-100%		-0,01
-0,01
0%














Announcement Date06/08/2018/08/2116/03/2211/05/2216/08/2216/08/2215/11/2222/03/2324/05/2330/08/2330/08/2320/11/2326/03/24-----

Upcoming sector events for BioLineRX Ltd.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for BioLineRX Ltd.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. Stock
  5. Calendar BioLineRX Ltd.